To have a successful low-dose CT (LDCT) lung cancer screening program, several stakeholders—including referring physicians, technologists and schedulers—need to understand key elements of the program. In part three of our video blog series about LDCT lung cancer screening programs, Leslie Ciancibello, RT, R, CT, from the...
Read more
In part two of our video blog series about low-dose CT lung cancer screening programs, Leslie Ciancibello, RT, R, CT, from the University Hospitals Seidman Cancer Center, discusses key factors that impact screening volume and inclusion/exclusion criteria. Factors that Impact LDCT Lung Cancer Screening Program Volume When...
Read more
Low-dose CT (LDCT) lung cancer screenings are growing in popularity, with hundreds (if not thousands) of hospitals in the consideration or initial stages of program implementation. Implementing a successful lung cancer screening program takes a coordinated effort. In our four part video blog series, Leslie Ciancibello, RT,...
Read more
If you’re an imaging provider, chances are something is keeping you up at night. There’s a lot to know with regard to the market, such as understanding sources of imaging volume growth and declines and predicting future utilization needs and rates. In a previous Cassling webinar presented by The Advisory Board Company,...
Read more
The Medicare program currently pays significantly different rates for services provided in different settings, and site-neutral payments have been considered as one way of eliminating the payment gap. However, that option has proven to be a contentious issue. In a previous Cassling webinar presented by The Advisory Board...
Read more
Marty Huebner, senior vice president of service for Cassling, summed up Bob Cassling’s influence on those whose lives he touched with one simple word. When asked what he learned from Bob, Marty said, “Everything.”
Read more
